AtriCure Appoints Shlomi Nachman to the Board of Directors

Verrica Pharmaceuticals Announces Receipt of Minutes from Type C Meeting with FDA Regarding Clinical Development of YCANTH™ for the Treatment of Common Warts

ROME Therapeutics Appoints Heike Keilhack, Ph.D., as Chief Scientific Officer

Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues

Octapharma Announces Availability of Balfaxar® For Warfarin Reversal in Urgent Surgery & Invasive Procedures

4DMT and Arbor Biotechnologies Establish Partnership to Co-Develop and Co-Commercialize Next-Generation Genetic Medicines for CNS Diseases

On Target Laboratories Names Scott Huennekens as Executive Chairperson of the Board

4DMT and Arbor Biotechnologies Establish Partnership to Co-Develop and Co-Commercialize Next-Generation Genetic Medicines for CNS Diseases

Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering

Processa Pharmaceuticals to Present at the Biotech Showcase 2024

 2   3   4   5   6     7    8   9   10   11   12